FDA Hires Torti As First Chief Scientist
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency taps outsider to develop its fellowship program.
You may also be interested in...
Woodcock Appointed As CDER Director
Acting director made permanent at FDA's drug center.
NDAs Should Include More Cross-Study Analysis, FDA Says In Draft Guidance
FDA is clarifying that it expects sponsors to provide analysis of efficacy data rather than simply a summary of clinical data as part of the integrated summary of effectiveness in new drug applications
New Look At Ezetimibe Fails To Confirm Vytorin Cancer Signal
Interim data from SHARP and IMPROVE-IT trials fail to show evidence of impact on cancer rates.